Insulin resistance in women often has no clear symptoms. When signs do appear, they may include waist weight gain, fatigue after meals, cravings, skin tags, dark velvety skin patches, irregular periods, or PCOS-related symptoms. The only way to know your risk is through a clinical evaluation and blood tests for prediabetes or diabetes 1.
Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.
See if you qualify →What does insulin resistance mean in women?
Insulin resistance means your cells do not respond to insulin as well as they should. The pancreas may make extra insulin for a while, so blood sugar can look normal before later rising into prediabetes or type 2 diabetes 1.
How insulin normally moves glucose into cells
Insulin is a hormone made by the pancreas. After you eat, carbohydrates break down into glucose, also called blood sugar. Insulin helps move glucose from the blood into muscle, fat, and liver cells so the body can use or store energy 1.
Why the pancreas may make more insulin before blood sugar rises
When cells respond less well to insulin, the pancreas may try to compensate by making more insulin. This higher-insulin state is called hyperinsulinemia. For some people, that compensation keeps blood glucose in range for years; for others, glucose rises over time 1.
Why many women have no symptoms at first
Insulin resistance and prediabetes are often silent. NIDDK notes that people with insulin resistance or prediabetes usually do not have symptoms, which is why risk-based testing matters 1. For a deeper primer, see our guide to what insulin resistance is.
What are the early symptoms of insulin resistance in women?
Early symptoms are not reliable enough to diagnose insulin resistance, but patterns can be worth checking. If several clues show up together—especially with family history, PCOS, past gestational diabetes, or weight change—blood sugar testing is a smart next step 1.
- Fatigue or energy crashes after meals. This can happen for many reasons, including sleep problems, anemia, thyroid disease, mood changes, or blood sugar swings, so it needs context.
- Stronger cravings for sweets or refined carbohydrates. Cravings alone do not prove high insulin, but they can be part of a broader metabolic pattern.
- Weight gain or difficulty losing weight, especially around the waist. Larger waist size and overweight or obesity are risk factors for insulin resistance and prediabetes 1.
- Feeling hungry soon after eating. Hunger can reflect meal composition, sleep, stress, medications, or blood sugar regulation.
- Brain fog or low daytime energy. These symptoms are common and nonspecific, so they should not be treated as a diagnosis.
- Skin tags. These can be benign, but new or increasing skin tags may appear with insulin resistance in some people 3.
- Dark, thicker, velvety skin patches called acanthosis nigricans. These patches often appear on the neck, armpits, groin, or under the breasts and can be linked with insulin resistance 3.
If you are trying to sort out a pattern, our overview of common signs of insulin resistance may help you prepare better questions for your clinician.
Can insulin resistance affect periods, PCOS, or fertility symptoms?
PCOS—polycystic ovary syndrome—often overlaps with insulin resistance, but they are not the same condition. Irregular periods, acne, excess facial hair, weight changes, and fertility concerns can have several causes, so cycle changes deserve medical evaluation 4.
PCOS is a hormone-related condition that can involve irregular ovulation, higher androgen levels, and metabolic risk. Reviews of women’s health research describe insulin resistance as an important part of PCOS and cardiometabolic risk for many patients, though not every woman with PCOS has the same pattern 4.
Human studies in PCOS have evaluated insulin-sensitizing approaches, including oral antidiabetic medications and other metabolic interventions, but those results should not be generalized to every woman with fatigue, cravings, or weight change 5, 6. If cycles become very irregular, bleeding changes sharply, or pregnancy is possible, testing should be individualized.
Are insulin resistance symptoms different after perimenopause or menopause?
Perimenopause and menopause can change sleep, body composition, waist size, and energy, and these changes can overlap with metabolic symptoms. Midlife weight gain does not automatically mean insulin resistance, but it can be a reason to check A1C, fasting glucose, lipids, blood pressure, and related risks 1.
After menopause, some women gain more visceral fat, the deeper belly fat linked with metabolic syndrome and type 2 diabetes risk. Women’s health reviews describe insulin resistance as relevant across reproductive and midlife stages, including PCOS and menopause-related cardiometabolic patterns 4.
Menopause symptoms can also mimic metabolic symptoms. Hot flashes, poor sleep, mood changes, and low energy may come from hormone shifts, stress, thyroid disease, anemia, depression, sleep apnea, or blood sugar problems. Trials in postmenopausal women show that menopausal symptom treatments can affect cardiometabolic markers in different ways, which is one reason midlife care should be individualized 7, 8.
What causes or raises the risk of insulin resistance in women?
Risk factors stack together. A person may have insulin resistance because of genetics, body composition, activity level, sleep, hormones, medications, or another health condition—not because of one single choice 1.
- Family history and age. Having a parent or sibling with type 2 diabetes raises risk, and NIDDK lists age 35 or older as a risk factor for prediabetes 1.
- Overweight, obesity, and larger waist size. Excess body fat, especially around the waist, is linked with insulin resistance and prediabetes risk 1.
- Low physical activity. Muscle is a major place where glucose is used, so regular movement supports insulin sensitivity 1.
- History of gestational diabetes. Past gestational diabetes raises later risk for prediabetes and type 2 diabetes 1.
- PCOS, sleep apnea, Cushing’s syndrome, acromegaly, and other conditions. NIDDK lists these among conditions linked with insulin resistance or prediabetes risk 1.
- Smoking and certain long-term medications. Smoking and medications such as glucocorticoids and some antipsychotic medications can raise metabolic risk 1.
- Fatty liver disease. Insulin resistance is linked with metabolic dysfunction-associated steatotic liver disease, formerly often called nonalcoholic fatty liver disease, and other cardiometabolic conditions 1.
How do you test for insulin resistance or prediabetes?
Blood tests are the practical way clinicians assess risk. Routine care often tests for prediabetes or diabetes rather than directly measuring insulin resistance 1.
Common tests include A1C, fasting plasma glucose, and an oral glucose tolerance test. A1C estimates average blood glucose over about 3 months, fasting glucose checks blood sugar after not eating, and an oral glucose tolerance test checks how your body handles a glucose drink over time 1. For more detail, read our guide to the A1C blood sugar test.
Some clinicians may consider fasting insulin or a calculated score called HOMA-IR in selected cases, often in research or specialty settings. A 2025 systematic review found that insulin resistance estimates vary partly because studies use different HOMA-IR cutoffs and methods 2.
- Ask which tests fit your risk factors: A1C, fasting glucose, oral glucose tolerance test, lipids, liver enzymes, blood pressure, or thyroid testing.
- Ask how often to repeat testing if results are normal but risk factors remain.
- Ask whether symptoms such as dark skin patches, new skin tags, irregular periods, or post-meal fatigue change the testing plan.
- Ask what results would mean for nutrition, activity, sleep, weight care, or medication discussions.
How is insulin resistance different from prediabetes?
Insulin resistance can happen before blood glucose becomes abnormal. Prediabetes means blood sugar is already above normal but not high enough for type 2 diabetes 1.
| Term | What it means | How it is usually found | Why it matters |
|---|---|---|---|
| Insulin resistance | Cells in muscle, fat, and liver do not respond to insulin as well as expected | Often inferred from risk factors, metabolic labs, or sometimes fasting insulin/HOMA-IR | Can raise risk for prediabetes, type 2 diabetes, metabolic syndrome, fatty liver disease, and cardiovascular risk 1 |
| Prediabetes | Blood glucose is higher than normal but not high enough for type 2 diabetes | A1C, fasting plasma glucose, or oral glucose tolerance test | Signals higher risk for type 2 diabetes, but lifestyle changes can help prevent or delay progression 1 |
| Type 2 diabetes | Blood glucose meets diabetes-range criteria | A1C, fasting plasma glucose, oral glucose tolerance test, or other diagnostic testing | Can affect the heart, eyes, kidneys, nerves, and other organs if not managed 1 |
If your main question is whether prediabetes can improve, see our article on whether prediabetes can be reversed.
What helps decrease insulin resistance?
The strongest first steps are the basics that improve blood sugar risk: nutrition, activity, strength training, sleep, smoking cessation, and weight loss when excess weight is present. These steps are not quick fixes, but they have the best overall risk-benefit profile 1.
Nutrition patterns that support steadier blood sugar
A steadier blood sugar pattern usually starts with meals that include protein, fiber-rich carbohydrates, healthy fats, and less added sugar or refined starch. This does not require a perfect diet. It means building meals that digest more slowly and support fullness.
Physical activity and strength training
Physical activity helps muscles use glucose. Strength training also matters because muscle is a major storage site for glucose. NIDDK recommends physical activity and reaching or maintaining a healthy weight to help prevent or reverse insulin resistance and prediabetes 1.
Weight loss when excess weight is present
If excess weight is part of your risk picture, weight loss can improve insulin sensitivity and blood sugar risk. That does not mean weight is the only driver. Sleep apnea, PCOS, medications, stress, and family history can still matter 1. Our guide to losing weight with insulin resistance explains how these pieces fit together.
Sleep, stress, smoking cessation, and related conditions
Sleep apnea, smoking, and some endocrine conditions can raise risk, so treating the underlying issue can be part of metabolic care 1. If fatigue is a major symptom, it is worth checking sleep, mood, thyroid, iron, B12, medications, and blood sugar risk rather than assuming insulin resistance is the cause.
When medication may be considered for related conditions
Medication may be discussed when someone has prediabetes, type 2 diabetes, PCOS, obesity, or another related diagnosis. Metformin has been studied in PCOS and insulin-resistance-related conditions, but medication choice depends on labs, pregnancy plans, symptoms, side effects, and personal risk 5.
3-min quiz
Wondering if weight care fits your metabolic health goals?
Chia’s online visit starts with a health questionnaire reviewed by a licensed US provider. If weight is part of your insulin-resistance risk picture, you can ask about clinician-guided options such as compounded semaglutide or compounded tirzepatide. A prescription requires a medical evaluation and is not guaranteed. Compounded medications are not FDA-approved.
Where can weight treatment fit if insulin resistance is part of the picture?
Weight treatment may fit when excess weight is contributing to metabolic risk, but it is not a stand-alone treatment for insulin resistance. Lifestyle care, testing, and treatment of related conditions still matter 1.
Semaglutide—known in brand contexts as Ozempic or Wegovy—is a GLP-1 receptor agonist. Tirzepatide—known in brand contexts as Mounjaro or Zepbound—is a dual GIP/GLP-1 receptor agonist. Compounded semaglutide via 503A pharmacy and compounded tirzepatide via 503A pharmacy are separate compounded prescriptions; they are not FDA-approved and do not have FDA-evaluated outcomes data.
These medications may be discussed for eligible patients seeking weight care, especially when weight is tied to blood sugar risk. They can cause side effects such as nausea, vomiting, diarrhea, constipation, reflux, dehydration, and appetite loss, and they may not be appropriate for people with certain medical histories, pregnancy, breastfeeding, or specific endocrine or gastrointestinal risks. A licensed clinician should review safety before treatment.
| If this sounds like you | Sensible next step | Why |
|---|---|---|
| You have symptoms but no labs yet | Ask a clinician about A1C, fasting glucose, and whether an oral glucose tolerance test fits | Symptoms alone cannot diagnose insulin resistance or prediabetes 1 |
| You have PCOS symptoms such as irregular periods, acne, excess facial hair, or fertility concerns | Seek evaluation with an OB-GYN, primary care clinician, or endocrinology clinician | PCOS can overlap with insulin resistance, but cycle changes need proper diagnosis 4 |
| You are in perimenopause or menopause with weight, sleep, and energy changes | Review metabolic labs and menopause symptoms together | Midlife symptoms can overlap; not every change is caused by insulin resistance 4 |
| You have excess weight plus blood sugar risk factors | Discuss lifestyle care and whether weight medication is appropriate | Weight loss can help metabolic risk when excess weight is present, but medication is not a stand-alone plan 1 |
| You are pregnant, trying to conceive, postpartum, or breastfeeding | Get individualized medical care before making diet, supplement, or medication changes | Blood sugar goals and medication safety are different in these life stages |
Weight-related care at Chia for women with insulin resistance concerns
At Chia, we do not diagnose insulin resistance from symptoms alone. We help eligible patients with clinician-reviewed weight care when weight is part of the metabolic-health picture, and we encourage appropriate lab testing with a clinician.
Chia offers compounded semaglutide injection and compounded tirzepatide tablets or injection, with microdosing plans available for both when clinically appropriate. Treatment starts with a short online health questionnaire. A licensed US provider reviews it and prescribes only when appropriate; a prescription is never guaranteed.
Medications are compounded in the US by state-licensed 503A compounding pharmacies and shipped to the patient’s door. Dosing is provider-guided and adjusted over time, and patients can message their care team through the patient portal between visits.
| Chia option | Forms listed in Chia’s catalog | Current starting price | May fit when |
|---|---|---|---|
| Semaglutide | Injection | Plans currently start at $249/mo | A licensed provider determines GLP-1 weight care is appropriate |
| Tirzepatide | Tablets or injection | Plans currently start at $249/mo for tablets and $299/mo for injection | A patient wants provider-guided weight care and a clinician agrees it fits |
| Weight + Energy | NAD+ injection + choice of GLP-1 | Plans currently start at $309/mo | An eligible patient is seeking weight care with an energy-focused protocol |
| Weight + Muscle | Sermorelin injection + choice of GLP-1 | Plans currently start at $329/mo | An eligible patient is seeking weight care with a muscle-focused protocol |
Some patients start with the eligibility quiz. Where supported, patients using AI tools may also access Chia through DoctorMCP at mcp.chia.health to begin the same clinician-reviewed path.
When should you see a clinician soon?
Get checked soon if symptoms are new, clustered, worsening, or paired with risk factors. Do not wait on home experiments if you have signs that could point to high blood sugar or another medical condition.
- Increased thirst, frequent urination, blurred vision, or unexplained weight loss, which can be signs of high blood glucose 1.
- History of gestational diabetes, PCOS, or strong family history of type 2 diabetes with new symptoms 1.
- Dark velvety skin patches, new skin tags, or several metabolic symptoms together 3.
- Pregnancy, trying to become pregnant, postpartum, or breastfeeding, because testing and medication decisions need individualized care.
- Severe fatigue, fainting, chest pain, shortness of breath, confusion, or rapid symptom changes.
3-min quiz
Start with a clinician-reviewed weight-care visit
If weight is part of your insulin-resistance risk picture, Chia can help you explore whether GLP-1 weight care or a protocol such as Weight + Energy or Weight + Muscle fits your goals. A licensed provider reviews your history and prescribes only when clinically appropriate; a prescription is not guaranteed.
FAQ
Many people have no warning signs. Possible clues include waist weight gain, fatigue after meals, cravings, hunger soon after eating, skin tags, dark velvety skin patches, and PCOS-like symptoms. These symptoms can have many causes, so blood tests and a clinical evaluation matter.
High insulin, or hyperinsulinemia, may not cause obvious symptoms. Some women notice cravings, hunger, weight gain, fatigue after meals, or skin changes, but these are not specific. A clinician can decide whether blood sugar testing or other labs are needed.
Insulin resistance and larger waist size often occur together, but the direction is not always simple. Visceral belly fat can worsen insulin resistance, and insulin resistance can make weight regulation harder for some people. Sleep, hormones, activity, medications, and genetics also matter.
Insulin resistance can overlap with PCOS, a condition that may cause irregular periods, acne, excess facial hair, and fertility concerns. But irregular periods can also come from thyroid disease, pregnancy, perimenopause, stress, under-eating, medications, or other hormone conditions. It is worth being evaluated.
Routine care usually tests related blood sugar risk rather than insulin resistance directly. Common tests include A1C, fasting plasma glucose, and an oral glucose tolerance test. Some clinicians may consider fasting insulin or HOMA-IR in selected cases.
Insulin resistance can often improve, especially when drivers such as inactivity, excess weight, poor sleep, smoking, sleep apnea, or certain medications are addressed. Improvement is personal and depends on the cause, lab results, and overall health.
No. Insulin resistance raises risk, but it does not mean type 2 diabetes is inevitable. Testing, nutrition changes, physical activity, weight loss when appropriate, sleep care, and treatment of related conditions can help lower risk.
GLP-1 and GIP/GLP-1 medications may be discussed for eligible patients seeking weight care or diabetes care, depending on the person and the product. They are not a guaranteed or stand-alone treatment for insulin resistance. Compounded semaglutide and compounded tirzepatide are not FDA-approved and do not have FDA-evaluated outcomes data.
References
- 1.National Institute of Diabetes and Digestive and Kidney Diseases. Insulin Resistance & Prediabetes. NIDDK. 2024.
- 2.Global prevalence of insulin resistance in the adult population: a systematic review and meta-analysis. Frontiers in Endocrinology. 2025.
- 3.Cleveland Clinic. Insulin Resistance: What It Is, Causes, Symptoms & Treatment. Cleveland Clinic. 2024.
- 4.Diamanti-Kandarakis E, Dunaif A. Insulin Resistance in Women's Health: Why It Matters. International Journal of Endocrinology. 2012.
- 5.Tauchert S, Schröder AK, Ortmann O, et al. The use of oral antidiabetic drugs in the treatment of polycystic ovary syndrome. Zentralblatt für Gynäkologie. 2003.
- 6.Rondanelli M, Riva A, Petrangolini G, et al. Berberine Phospholipid Is an Effective Insulin Sensitizer and Improves Metabolic and Hormonal Disorders in Women with Polycystic Ovary Syndrome: A One-Group Pretest-Post-Test Explanatory Study. Nutrients. 2021.
- 7.Palma F, Fontanesi F, Neri I, et al. Blood pressure and cardiovascular risk factors in women treated for climacteric symptoms with acupuncture, phytoestrogens, or hormones. Menopause. 2020.
- 8.Matsui S, Yasui T, Tani A, et al. Effect of ultra-low-dose estradiol and dydrogesterone on arterial stiffness in postmenopausal women. Climacteric. 2014.
- 9.Kujala SM, Pöyhönen-Alho M, Kaaja RJ. Effects of sympatholytic therapy on postmenopausal symptoms in hypertensive postmenopausal women. Climacteric. 2014.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
See if GLP-1 is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.



